Skip to main content
. 2008 Sep 10;26(26):4311–4318. doi: 10.1200/JCO.2008.16.7858

Table 2.

National Cancer Institute Common Terminology Criteria for Adverse Events Version 3.0 Grade 3 and 4 Adverse Events

Toxicity RAD001 (mg)
All
5
10
No % No % No %
No. of patients 34 32 64
Hematologic
    Thrombocytopenia 1 3 2 6 3 5
    Anemia 1 3 1 3 2 3
    Leukopenia 1 3 2 6 3 5
    Leukocytosis 1 3 1 2
Biochemical
    Hyperglycemia 1 3 5 16 6 9
    Hypertriglyceridemia 2 6 2 3
    Hypoglycemia 2 6 2 3
    Elevated AST 1 3 2 6 3 5
    Hypophosphatemia 2 6 5 16 7 11
    Elevated ALT 3 9 3 5
    Hypokalemia 1 3 1 3 2 3
    Hyperbilirubinemia 1 3 1 2
Other
    Apthous ulcers* 2 6 3 9 5 8
    Fatigue 5 15 2 6 7 11
    Nausea 1 3 1 2
    Nail changes 1 3 1 2
    Diarrhea 3 9 4 13 7 11
    Pain 2 6 2 3
    Rash 2 6 1 3 3 5
    Abdominal pain 2 6 2 2
    Pruritus 1 3 1 2
    Dysgeusia 1 3 1 2
    Pneumonitis 1 3 1 2

Abbreviation: RAD001, everolimus.

*

Graded as stomatitis under National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0.